B-Raf IN 9
B-Raf IN 9 (compound 8b) is a potent B-Raf inhibitor, with an IC50 of 24.79 nM. B-Raf IN 9 induces apoptosis and shows cell cycle arrest at G2/M phase. B-Raf IN 9 exhibits potent antitumor activity against human prostate cancer PC-3 cell line, with an IC50 of 7.83 µM[1].
Product Specifications
CAS Number
2477725-18-9
UNSPSC
12352005
Target
Apoptosis; Raf
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/b-raf-in-9.html
Solubility
10 mM in DMSO
Smiles
S=C(NC1=CC=CC=C1)NC2=CC=C(C(CC3)=NN(C4=CC=CC=C4)C3=O)C=C2
Molecular Formula
C23H20N4OS
Molecular Weight
400.50
References & Citations
[1]Thabit MG, et al. Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity. Bioorg Chem. 2020 Oct;103:104148.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
B-Raf
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
133955-ML550 100 µL
STEAP1 (Six-transmembrane Epithelial Antigen of Prostate 1, Metalloreductase STEAP1, STEAP, PRSS24) (MaxLight 550)
Sign In for Pricing
View Details 